INS and type 2 diabetes mellitus: Retinol-binding protein 4 (RBP4) is a plasma retinoid transporter detected in the early phase of insulin resistance conditions, such as in T2DM and MS; its inhibition allowed an increase in insulin sensitivity in animal trials [46].